J Gynecol Oncol > v.29(1)

17 results

e1 Role of lymphadenectomy in intermediate-risk endometrial cancer: a matched-pair study
Pluvio J. Coronado, Agnieszka Rychlik, Maria A. Martínez-Maestre, Laura Baquedano, María Fasero, Aida García-Arreza, Sara Morales, Daniel M. Lubian, Ignacio Zapardiel
KMSID: 1093878   J Gynecol Oncol. 2018;29(1):e1.  Published online 2017 September 8    DOI: http://dx.doi.org/10.3802/jgo.2018.29.e1
         
e2 Robotic single site radical hysterectomy plus pelvic lymphadenectomy in gynecological cancers
Enrico Vizza, Benito Chiofalo, Giuseppe Cutillo, Emanuela Mancini, Ermelinda Baiocco, Ashanti Zampa, Arabella Bufalo, Giacomo Corrado
KMSID: 1093889   J Gynecol Oncol. 2018;29(1):e2.  Published online 2017 September 12    DOI: http://dx.doi.org/10.3802/jgo.2018.29.e2
         
e3 Pazopanib monotherapy in the treatment of pretreated, metastatic uterine sarcoma: a single-center retrospective study
Hyun-Jun Kim, Youjin Kim, Su Jin Lee, Jeeyun Lee, Se Hoon Park
KMSID: 1093900   J Gynecol Oncol. 2018;29(1):e3.  Published online 2017 September 25    DOI: http://dx.doi.org/10.3802/jgo.2018.29.e3
         
e4 Mutational analysis of KRAS and its clinical implications in cervical cancer patients
Wei Jiang, Libing Xiang, Xuan Pei, Tiancong He, Xuxia Shen, Xiaohua Wu, Huijuan Yang
KMSID: 1093911   J Gynecol Oncol. 2018;29(1):e4.  Published online 2017 September 26    DOI: http://dx.doi.org/10.3802/jgo.2018.29.e4
         
e5 Oncologic outcomes of adjuvant chemotherapy alone after radical surgery for stage IB–IIA cervical cancer patients
Kwang-Beom Lee, Young Saing Kim, Jong-Min Lee
KMSID: 1093917   J Gynecol Oncol. 2018;29(1):e5.  Published online 2017 October 10    DOI: http://dx.doi.org/10.3802/jgo.2018.29.e5
         
e6 Clinical outcomes and risk of recurrence among patients with vaginal intraepithelial neoplasia: a comprehensive analysis of 576 cases
Mi-Kyung Kim, In Ho Lee, Ki Heon Lee
KMSID: 1093919   J Gynecol Oncol. 2018;29(1):e6.  Published online 2017 October 10    DOI: http://dx.doi.org/10.3802/jgo.2018.29.e6
         
e7 Epidemiology of gynecologic cancers in China
Xiyi Jiang, Huijuan Tang, Tianhui Chen
KMSID: 1093920   J Gynecol Oncol. 2018;29(1):e7.  Published online 2017 November 1    DOI: http://dx.doi.org/10.3802/jgo.2018.29.e7
         
e8 Are vaginal swabs comparable to cervical smears for human papillomavirus DNA testing?
Liselotte Coorevits, Ans Traen, Luc Bingé, Jo Van Dorpe, Marleen Praet, Jerina Boelens, Elizaveta Padalko
KMSID: 1093921   J Gynecol Oncol. 2018;29(1):e8.  Published online 2017 October 30    DOI: http://dx.doi.org/10.3802/jgo.2018.29.e8
         
e9 Baseline risk of recurrence in stage I–II endometrial carcinoma
Shinsuke Sasada, Mayu Yunokawa, Yae Takehara, Mitsuya Ishikawa, Shunichi Ikeda, Tomoyasu Kato, Kenji Tamura
KMSID: 1093922   J Gynecol Oncol. 2018;29(1):e9.  Published online 2017 November 16    DOI: http://dx.doi.org/10.3802/jgo.2018.29.e9
         
e10 Quality and quantity metrics of pelvic lymph node metastasis and risk of para-aortic lymph node metastasis in stage IB–IIB cervical cancer
Koji Matsuo, Brendan H. Grubbs, Mikio Mikami
KMSID: 1093879   J Gynecol Oncol. 2018;29(1):e10.  Published online 2017 November 3    DOI: http://dx.doi.org/10.3802/jgo.2018.29.e10
         
e11 Risk stratification models for para-aortic lymph node metastasis and recurrence in stage IB–IIB cervical cancer
Koji Matsuo, Muneaki Shimada, Tsuyoshi Saito, Kazuhiro Takehara, Hideki Tokunaga, Yoh Watanabe, Yukiharu Todo, Ken-ichirou Morishige, Mikio Mikami, Toru Sugiyama
KMSID: 1093880   J Gynecol Oncol. 2018;29(1):e11.  Published online 2017 November 10    DOI: http://dx.doi.org/10.3802/jgo.2018.29.e11
         
e12 Impact of lymph node ratio on survival in stage III ovarian high-grade serous cancer: a Turkish Gynecologic Oncology Group study
Ali Ayhan, Nazlı Topfedaisi Ozkan, Mustafa Erkan Sarı, Husnu Celik, Murat Dede, Özgür Akbayır, Kemal Güngördük, Hanifi Şahin, Ali Haberal, Tayfun Güngör, Macit Arvas, Mehmet Mutlu Meydanlı
KMSID: 1093928   J Gynecol Oncol. 2018;29(1):e12.  Published online 2017 November 9    DOI: http://dx.doi.org/10.3802/jgo.2018.29.e12
         
e13 Prognostic significance of normal-sized ovary in advanced serous epithelial ovarian cancer
E Sun Paik, Ji Hye Kim, Tae-Joong Kim, Jeong-Won Lee, Byoung-Gie Kim, Duk-Soo Bae, Chel Hun Choi
KMSID: 1093882   J Gynecol Oncol. 2018;29(1):e13.  Published online 2017 November 9    DOI: http://dx.doi.org/10.3802/jgo.2018.29.e13
         
e14 Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014–2016
Yung-Taek Ouh, Kyung-Jin Min, Hyun Woong Cho, Moran Ki, Jin-Kyoung Oh, Sang Yop Shin, Jin Hwa Hong, Jae-Kwan Lee
KMSID: 1093883   J Gynecol Oncol. 2018;29(1):e14.  Published online 2017 November 11    DOI: http://dx.doi.org/10.3802/jgo.2018.29.e14
         
e15 Trends of low-grade serous ovarian carcinoma in the United States
Koji Matsuo, Hiroko Machida, Brendan H. Grubbs, Anil K. Sood, David M. Gershenson
KMSID: 1093884   J Gynecol Oncol. 2018;29(1):e15.  Published online 2017 November 7    DOI: http://dx.doi.org/10.3802/jgo.2018.29.e15
         
e16 Survival benefit of patients with early-stage ovarian carcinoma treated with paclitaxel chemotherapeutic regimens
Chien-An Chen, Chun-Ju Chiang, Yun-Yuan Chen, San-Lin You, Shu-Feng Hsieh, Chao-Hsiun Tang, Wen-Fang Cheng
KMSID: 1093885   J Gynecol Oncol. 2018;29(1):e16.  Published online 2017 November 10    DOI: http://dx.doi.org/10.3802/jgo.2018.29.e16
         
e17 The feasibility of detecting endometrial and ovarian cancer using DNA methylation biomarkers in cervical scrapings
Cheng-Chang Chang, Hui-Chen Wang, Yu-Ping Liao, Yu-Chih Chen, Yu-Chun Weng, Mu-Hsien Yu, Hung-Cheng Lai
KMSID: 1094753   J Gynecol Oncol. 2018;29(1):e17.  Published online 2017 November 16    DOI: http://dx.doi.org/10.3802/jgo.2018.29.e17
         
Articles from Journal of Gynecologic Oncology are provided here courtesy of Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology